The marketing authorisation for Vaxzevria (SRD) has been withdrawn at the request of the marketing-authorisation holder.
Therapeutic Indication
### Therapeutic indication Vaxzevria is indicated for active immunisation to prevent COVID 19 caused by SARS CoV 2, in individuals 18 years of age and older. The use of this vaccine should be in accordance with official recommendations.
Therapeutic Area (MeSH)
N/AATC Code
J07BN02
ATC Item
covid-19, viral vector, non-replicating
Pharmacotherapeutic Group
Vaccines
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| ChAdOx1-SARS-COV-2 | N/A | chadox 1-sars-cov-2 |
EMA Name
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
Medicine Name
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
Aliases
N/A